CHI3L1 and Parkinson disease: These findings suggest an interplay between Chi3l1 and mitochondrial function in PD, suggesting that the combination of Chi3l1 levels and changes in mitochondrial function might be used to more effectively evaluate inflammatory activity and the clinical course of PD.